Black Eyed Saint

Read About Just About Anything

Carsten Thiel April 15, 2019


When people think of biotechnology, , they coin it the “Golden Age.” Indeed, Carsten Thiel is right in the thick of this biotechnology milieu.

Indeed, many experts in the biotechnology field, such as Carsten Thiel, believe that we’re entering a real Golden Age of Biotech. Moreover, some in the biotech world believe that the effects of biotech will be truly profound for many reasons. For one, the biotechnology sector is getting to a point where the human race can pinpoint issues and find solutions for them, more than ever thanks to the full sequencing of the human gene, which occurred in 1995. And in that year, sequencing the first genome came with a price tag of 2.7 billion USD.

In 2008, the cost was nearly 10 million. However, the cost to do the same process costs one 1 thousand dollars USD, which says a lot about how the price of certain areas of biotech and genomics has changed. This is good for those biotech experts who are in this area of research. Indeed, when it comes to living long, yet healthier lives, biotechnology is on the forefront. Carsten Thiel and other leading minds would agree with the notion that a life that is eventually free of disease is not a work of science fiction.

An article with Medical Daily Times entitled “Carsten Thiel: Impactful Medicine”, talks about Thiel’s leadership, expertise, professional experience and contribution to the world of Biotechnology.

He supports CRISPR which is a technology that is helping to make the Golden Age of biotech come to fruition. Many in biotech believe that cellular (biology) engineering is part of the big wave in this milieu.

CRISPR-Cas9 is a hot genome editing mechanism that is a popular one right now. This tool helps to make critical changes in his cells. And the manipulation of cells by researchers is possible ex vivo and in vivo. This cell manipulation was deemed highly unlikely many decades ago, but the “Golden Age” is upon us.